Recruiting
Phase 1
Phase 2

Siltuximab

Sponsor:

Brian Miller

Code:

NCT02796859

Conditions

Schizophrenia

Psychotic Disorders

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Siltuximab

normal saline

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-02. This information was provided to ClinicalTrials.gov by Brian Miller on 2023-07-21.